Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Status:
RECRUITING
Trial end date:
2025-12-22
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.